Effects of lorcaserin on pre‐existing valvulopathy: A pooled analysis of phase 3 trials

OBJECTIVE: To evaluate the effects of lorcaserin in patients with pre‐existing Food and Drug Administration (FDA)‐defined valvulopathy. METHODS: This is a pooled, post hoc analysis of three Phase 3 studies. BLOOM and BLOSSOM patients were 18 to 65 years of age without diabetes and with a body mass i...

Descripción completa

Detalles Bibliográficos
Autores principales: Weissman, Neil J., Smith, Steven R., Fain, Randi, Hall, Nancy, Shanahan, William R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6680283/
https://www.ncbi.nlm.nih.gov/pubmed/27888609
http://dx.doi.org/10.1002/oby.21695

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6680283/
https://www.ncbi.nlm.nih.gov/pubmed/27888609
http://dx.doi.org/10.1002/oby.21695

Ejemplares similares